Wood Tarver Financial Group, LLC Gilead Sciences, Inc. Transaction History
Wood Tarver Financial Group, LLC
- $258 Million
- Q1 2025
A detailed history of Wood Tarver Financial Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wood Tarver Financial Group, LLC holds 231 shares of GILD stock, worth $25,049. This represents 0.01% of its overall portfolio holdings.
Number of Shares
231
Previous 231
-0.0%
Holding current value
$25,049
Previous $21,000
19.05%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.45 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.92 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.81 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $136B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...